INDICATION
ROUTE
DEVELOPMENT STAGE
RayVa™
Raynaud's Syndrome Secondary scleroderma
Topical
IND to be filed (Phase III)
PsoriaVa™
Psoriasis
Pre-IND
Lidocaine
Pain
